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Abstract
Background: Soshiho-tang, known as Xio-hai-Hu-Tang in Chinese and Sho-Saiko-to in Japanese, has been widely
used as a therapeutic agent. Its pharmacological effects include anti-inflammatory, antioxidant, antihepatic fibrosis,
antitumor and immunomodulating activities. However, little is known regarding its effects on allergic asthma.
Therefore, the aim of the present study was to investigate whether the Soshiho-tang water extract (SSTW) has
antiasthmatic effects on airway inflammation in an ovalbumin (OVA)-induced mouse model.
Methods: BALB/c mice were used as a model of asthma after induction by sensitization and challenge with OVA.
We measured change in eosinophils, other inflammatory cells, and T helper 2 (Th2)-type cytokines, such as interleukin
(IL)-4, IL-5, IL-13, IL-17, IL-33, and chemokine (eotaxin) in bronchoalveolar lavage fluid (BALF), presence of total
and OVA-specific immunoglobulin (Ig)E in plasma, and expression of mucus production and heme oxygenase
(HO)-1 protein in lung tissue.
Results: Our results show that SSTW had a suppressive effect on eosinophil influx into BALF and decreased the
levels of Th2-type cytokines. Moreover, SSTW exhibited a marked decrease in mucus hypersecretion, total and
OVA-specific IgE levels, and significantly induced HO-1 protein expression.
Conclusions: These results suggest that SSTW may be used as a valuable therapeutic agent for treating various
inflammatory diseases including allergic asthma.
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Background
Asthma is a complex disorder associated with T helper 2
(Th2) immune responses to allergens characterized by air-
way obstruction and pulmonary inflammation that affects
approximately 300 million people worldwide [1]. It is now
well recognized that asthma is caused by Th2-driven in-
flammatory responses, which enhance airway eosinophilia
and lung mucus production [2]. Allergic immune response
is initiated by activation of allergen-specific Th2 cells, re-
lease of the Th2-type cytokines interleukin (IL)-4, IL-13
coupled with an increase in immunoglobulin (Ig)E, and lo-
calized eosinophilia [3].
CD4+ T-cells play a crucial role in immune protection
via their capacity to help B cells make antibodies, recruit
eosinophils to sites of inflammation, and through their
production of cytokines and chemokines [4]. Th2-type
cytokines, including IL-4, IL-5, IL-13, IL-17, and IL-33
produced by activated CD4+ T-cells, enhance IgE pro-
duction, eosinophil accumulation [5], and play a central
role in the pathogenesis of asthma [6]. Therefore, sup-
pression of Th2-type cytokine production by activated
CD4+ T-cells may prove to be a useful therapeutic ap-
proach to the treatment of inflammatory immune dis-
eases such as allergic asthma.
A stress-response protein, heme oxygenase (HO)-1, is
a cytoprotective mechanism against oxidative cellular in-
jury [7]. It is induced by various stress stimuli, including
hemin, oxidative stress, endotoxins, and hypoxia in vari-
ous cell types [8]. Resent, basic study show that HO-1, a
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protective gene, and its overexpression have significant
cytoprotection properties such as antioxidative and anti-
inflammatory effects as well as mediation of cell-cycle
activities [9]. Therefore, the present study focused on
whether Soshiho-tang has an antiasthmatic effect via up-
regulation of HO-1 in an ovalbumin (OVA)-induced
asthmatic model.
Soshiho-tang, known as Xio-Chai-Hu-Tang in Chinese
and Sho-Saiko-to in Japanese, is frequently used for
treatment of pulmonary disorders such as the common
cold and pneumonitis [10]. It is composed of seven
herbs: Bupleuri Radix, Scutellariae Radix, Ginseng Radix,
Pinelliae Tuber, Glycyrrhizae Radix et Rhizoma, Zingiberis
Rhizoma Crudus, and Zizyphi Fructus (Table 1). According
to previous experimental reports, Soshiho-tang has a var-
iety of confirmed pharmacological effects such as anti-
inflammatory [11], antioxidant [12], and immunoregulation
[13] activities. Several biological activities of Soshiho-tang
have been reported to date; however, there are still no valid
studies of its underlying OVA-induced asthmatic effects.
Therefore, we investigated the antiallergic effect related to
inflammation and oxidative stress of Soshiho-tang water ex-
tract (SSTW) on the treatment of bronchial asthma using
an OVA-induced mouse model. To our knowledge, this is
the first study to provide experimental evidence that
Soshiho-tang has antiasthma effects in an OVA-induced
murine asthma model.
Methods
Preparation of the SSTW
The water extract of Soshiho-tang (2008-KE26) was de-
posited in the K-herb Research Center, Korea Institute
of Oriental Medicine (KIOM). Soshiho-tang was pre-
pared in our laboratory from a mixture of chopped
crude herbs purchased from Omniherb (Korea) and
HMAX (China). The identity of each crude herb was con-
firmed by Professor Je-Hyun Lee at the Oriental College
of Dongguk University (Gyeongju, Republic of Korea). A
herbal decoction of Soshiho-tang was prepared with a
mixture of herbal medicines according to composition in
the laboratory (Table 1). The aqueous preparation were
extracted in distilled water at 100 °C for 120 min. The ex-
tract solution was evaporated to dryness and then frozen
to dry powder (yield, 22.9 %). The extracted Soshiho-tang
powder was stored at 4 °C.
Animals
Specific pathogen-free female BALB/c mice (seven weeks
old) were purchased from the Orient Co. (Seoul, Korea).
Mice were maintained in an animal facility under stand-
ard laboratory conditions for 1 week of quarantine and
acclimatization prior to experiments, and provided water
and standard chow ad libitum. The animal experimental
procedures were approved by the Korea Institute of
Oriental Medicine Institutional Animal Care and Use
Committee and performed in compliance with the
National Institute of Health Guidelines for the care and
use of laboratory animals and the Korean National Animal
Welfare Law.
Induction of allergic asthma and experimental design
To induce asthma, OVA sensitization and airway chal-
lenge were performed as described previously [14, 15].
The mice were sensitized on days 0 and 14 by intraperi-
toneal injection of 20 μg OVA emulsified in 2 mg
aluminum hydroxide in 200 μL phosphate buffered sa-
line (PBS) buffer (pH 7.4). On days 21, 22, and 23, the
mice received an airway challenge with OVA (1 %, w/v,
in PBS) for 1 h using an ultrasonic nebulizer (NE-U12;
Omron Corp., Tokyo, Japan). SSTW was completely dis-
solved in PBS and was prepared fresh daily before each
treatment. SSTW was administered by oral gavage to
mice at doses of 100 and 200 mg/kg once daily from
days 18 to 23. Negative and positive control mice were
orally administered PBS and montelukast (Mon, 30 mg/
kg in PBS), respectively. Mon is a potent, selective
cysteinyl leukotriene 1 (CysLT1) receptor antagonist [16]
and was introduced into the market after successful clinical
evaluation in patients with aspirin-sensitive asthma, noctur-
nal exacerbation of asthma, and allergic asthma [17].
At the end of OVA challenge, bronchoalveolar lavage
fluid (BALF) samples were obtained from the trachea of
mice and processed. Inflammatory cells were counted as
described previously [14, 15]. In brief, the mice were
sacrificed by intraperitoneal injection of pentobarbital
(50 mg/kg; Hanlim Pharm. Co., Seoul, Korea) 48 h after
the last challenge, and a tracheostomy was performed.
To collect the BALF, ice-cold PBS (0.5 mL) was infused
into the lung and withdrawn through tracheal cannula-
tion three times (total volume 1.5 mL). The total inflam-
matory cell numbers were assessed by counting cells in
at least five squares of a hemocytometer after exclusion
of dead cells by trypan blue staining. To determine dif-
ferential cell counts, 100 μL of BALF was centrifuged
Table 1 Crude components of Soshiho-tang
Scientific name Amount (g) Company
of purchase
Source
Bupleuri Radix 11.25 (31.6 %) Omniherb Korea
Scutellariae Radix 7.5 (21.1 %) HMAX China
Ginseng Radix 3.75 (10.5 %) Omniherb Korea
Pinelliae Tuber 3.75 (10.5 %) Omniherb Korea
Glycyrrhizae Radix
et Rhizoma
1.875 (5.3 %) HMAX China
Zingiberis Rhizoma Crudus 3.75 (10.5 %) Omniherb Korea
Zizyphi Fructus 3.75 (10.5 %) Omiherb Korea
Total amount 35.625 (100 %)
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onto slides using a Cytospin unit (Hanil Science Indus-
trial, Seoul, Korea) (200 g, 4 °C, 10 min). The slides were
dried, and the cells were fixed and stained using Diff-
Quik® staining reagent (B4132-1A; IMEB Inc., Deerfield,
IL), according to the manufacturer’s instructions. The
supernatant obtained from BALF was stored at −70 °C
for biochemical analysis. Blood samples were obtained
from the mice via the inferior vena cava. Plasma was
collected via centrifugation (200 g, 4 °C, 10 min) and
stored at −70 °C.
Measurement of the levels of Th2-type cytokines and che-
mokine in BALF
The levels of IL-4, IL-5, IL-13, IL17, IL-33 and eotaxin
in BALF were measured using enzyme-linked immuno-
sorbent assay (ELISA) kits (BioSource International,
Camarillo, CA) according to the manufacturer’s proto-
cols. The detection range of IL-13 is 3.9 pg/mL to
250 pg/mL, and IL-17 is 7.1 pg/mL to 450 pg/mL, and
IL-5 is 7.8 pg/mL to 500 pg/mL. The detection ranges of
IL-4 are 15.6 pg/mL to 1000 pg/mL, and eotaxin and IL-
33 are 31.25 pg/mL to 2000 pg/mL.
Measurement of total and OVA-specific IgE in plasma
The levels of total IgE and OVA-specific IgE in plasma
were measured as described previously [18]. Microtiter
plates were coated with anti-IgE antibodies (anti-mouse
IgE; 10 g/mL; Serotec, Oxford, UK) in PBS-Tween 20,
and incubated with plasma sample. The plates were then
washed four times, and 200 μL of o-phenylenediamine
dihydrochloride (Sigma-Aldrich, St. Louis, MO) was
added to each well. The plates were incubated for
10 min in the dark and the absorbance was then mea-
sured at 450 nm.
Lung tissue histopathological studies
For histopathological examination, the lung tissues
were stained as described previously [19]. The 4 %
paraformaldehyde-fixed tissues were embedded in paraf-
fin, sectioned at 4 μm thickness, and stained with
hematoxylin and eosin (H&E) stain solution (hematoxylin;
Sigma MHS-16 and eosin; Sigma HT110-1-32) and peri-
odic acid − Schiff (PAS) (IMEB Inc., San Marcos, CA) to
measure inflammatory cell accumulation and mucus pro-
duction, respectively. Quantitative analysis for airway in-
flammation and mucus secretion was evaluated using a
MetaMorph Offline version 7.7.0.0 image analysis software
(Molecular Devices Inc., Sunnyvale, CA, USA).
HO-1 enzyme activity in lung tissue
HO-1 enzyme activity was assessed as described previously
[19]. Briefly, lungs were homogenized on ice in one volume
of 100 mmol/L phosphate buffer with 2 mmol/L MgCl2,
and centrifuged for 15 min at 18,800 g. The supernatant
was used to measure HO-1 enzyme activity. ELISA assays
were performed according to the manufacturer’s instruc-
tions. The HO-1 level in lung tissue was estimated using a
specific mouse HO-1 ELISA kit (DAKARA, Japan). Activity
values were expressed on a per-mg-protein basis.
Immunohistochemistry
Immunohistochemistry assay were performed as de-
scribed previously [19]. Paraffin sections were deparaffi-
nized, dehydrated, and washed in PBS with 0.3 % Triton
X-100. Slides were preincubated for 10 min at room
temperature with 10 % goat serum to block nonspecific
staining, and then incubated with mouse anti-rabbit
HO-1 primary antibody (1:200; Abcam, Cambridge, UK)
overnight at 4 °C. After removal of primary antibody,
slides were washed and incubated with biotinylated sec-
ondary antibody at 37 °C for 1 h and then with the
avidin–biotin–peroxidase complex (Vector Laboratories,
Burlingame, CA) for 1 h at room temperature. Excess
secondary antibody was removed, and slides were
washed with PBS and incubated with 0.05 % diamino-
benzidine (1:200; Millipore, Billerica, MA) for 10 min. Sec-
tions were counterstained, rinsed in PBS to terminate the
reaction, and coverslipped for microscopic examination.
Image capture and photomicrography
Photomicrographs were taken using a Photometric Quantix
digital camera running a Windows program, and montages
were assembled in Adobe Photoshop 7.0. Images were
cropped and corrected for brightness and contrast,
but were not otherwise manipulated as described pre-
viously [18].
Statistical analysis
Data are expressed as means ± standard error of the
mean (SEM). Statistical significance was determined
using analysis of variance (ANOVA) followed by mul-
tiple comparison tests with Bonferroni adjustment. Dif-
ferences in P values < 0.05 or < 0.01 were considered
statistically significant.
Results
Effects of SSTW on number of eosinophils and other
inflammatory cells in BALF
To investigate the anti-inflammation effect of SSTW on
the eosinophilia in OVA-induced asthmatic mice, we de-
termined the number of total cells including eosinophils
and other inflammatory cells in BALF. As shown in
Fig. 1, the number of total cells, eosinophils, and other
inflammatory cells in the OVA-induced group was sig-
nificantly higher when compared with the NC group
with PBS-induced mice. However, a positive control
drug in this study, Mon group dramatically decreased
the number of total cells and eosinophils compared with
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the OVA-induced group. Administration of SSTW (100
and 200 mg/kg) strongly exhibited a suppressive effect
on eosinophilia influx into BALF.
Effects of SSTW on OVA-induced cytokines and chemo-
kine level in BALF
To determine the possible effects on the T-cell response
associated with asthmatic mice, we evaluated the Th2-
type cytokines and chemokine level in BALF. Figure 2
shows that the OVA-induced group had significantly ele-
vated Th2-type cytokine and chemokine levels compared
with the NC group. However, Mon- and SSTW-treated
groups (100 and 200 mg/kg) had significantly decreased
levels of Th2-type cytokines, including IL-4 (Fig. 2a), IL-
5 (Fig. 2b), IL-13 (Fig. 2c), IL-17 (Fig. 2d), IL-33 (Fig. 2e),
and chemokine such as eotaxin (Fig. 2f ), compared with
those from the OVA-induced group.
Effects of SSTW on inflammatory cell accumulation and
mucus production in lung tissue
To evaluate the inhibitory effect on the histological
change in the lung tissue of OVA-induced asthmatic
mice, we stained lung sections with H&E stain solution
and PAS. The infiltration of leukocytes in the peribron-
chial/peribronchiolar lung tissue was not detected in the
NC group with PBS-induced mice.
In contrast, the OVA-induced group showed the infil-
tration of leukocytes such as inflammatory cell accumu-
lation of high density. However, treatment with SSTW
(100 and 200 mg/kg) effectively suppressed inflamma-
tory cell numbers in lung tissue (Figs. 3a and c). Mucus
overproduction in the OVA-induced group was clearly
observed as a violet color in the bronchial airways
compared with the NC group. However, administra-
tion of Mon and SSTW (100 and 200 mg/kg) signifi-
cantly decreased the mucus hypersecretion in lung
tissue (Figs. 3b and d).
Effects of SSTW on the release of IgE levels
To confirm the association with Th2-type responses in
the plasma of OVA-induced asthmatic mice, we mea-
sured the total and OVA-specific IgE levels in plasma.
Total and OVA-specific IgE levels in plasma were mark-
edly elevated in the OVA-induced group compared with
the NC group. The Mon and SSTW groups (100 and
200 mg/kg) had significantly decreased total and OVA-
specific IgE levels in plasma compared with the OVA-
induced mice (Figs. 4a and b).
Effects of SSTW on HO-1 level and protein expression
To determine the HO-1 protein expression associated
with asthmatic mice, we evaluated the HO-1 level and
protein expression by ELISA and immunohistochemis-
try. As shown in Fig. 5a, the HO-1 level in homogenized
lung tissue significantly increased in the OVA-induced
group compared with the NC group. Moreover, adminis-
tration of SSTW (100 and 200 mg/kg) gradually in-
creased more than the OVA-induced group in a dose-
dependent manner. These results were consistent with
immunohistochemistry analysis. HO-1 protein expres-
sion markedly increased in the OVA-induced group
compared with the NC group. SSTW treatment (100
and 200 mg/kg) strongly increased HO-1 protein expres-
sion compared with the OVA-induced group (Fig. 5b).
Fig. 1 Effects of SSTW on recruitment of inflammatory cells in BALF of OVA-mice. Cells were isolated by cytospin and stained with Diff-Quick. Cell
numbers were determined using a light microscope to count cells in at least five squares of a hemocytometer after excluding dead cells using
trypan blue. NC, normal control group (PBS only); OVA, OVA-induced group; Mon, montelukast (30 mg/kg) + OVA-induced group; SSTW-100, SSTW
(100 mg/kg) + OVA-induced group; SSTW-200, SSTW (200 mg/kg) + OVA-induced group. Each bar represents the mean ± SEM (n = 6 per group).
Significant differences at ##P < 0.01 and #P < 0.05 compared with the NC group. Significant differences at *P < 0.05 and **P < 0.01 compared with
the OVA-induced group
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Discussion
The objective of this study was to evaluate the antiasth-
matic effect of SSTW in an asthma-induced mouse
model by OVA. We investigated the influx of inflamma-
tory cells (particularly, eosinophils) and Th2-type cyto-
kines including IL-4, IL-5, IL-13, IL-17, IL-33, and
chemokine (eotaxin) into the BALF, IgE levels in plasma,
inflammatory cell infiltration, mucus production, and
HO-1 protein expression in lung tissue. Our results indi-
cate that SSTW significantly decreased the airway in-
flammation by suppressing the influx of inflammatory
cells as eosinophilia, increased Th2-type cytokines, che-
mokine, IgE levels, and mucus hypersecretion, and grad-
ually increased the HO-1 expression related to oxidative
stress.
Soshiho-tang is a traditional herbal medicine used specif-
ically to treat alternating chills and fever, hardness and full-
ness in the hypochondrium, dry retching, and bitter taste in
the mouth. Moreover, it is probably one of the most exten-
sively investigated herbal formulas as experimental and
clinical data have been accumulating worldwide [13]. Based
on previous studies, among the constituents of the mixed
herbal Soshiho-tang, we can assume that the beneficial ef-
fects in this allergic asthma model are via the antiasthmatic
effect of Pinelliae Tuber [20], the antiallergic effect of Zingi-
beris Rhizoma Crudus [21], the anti-inflammatory effect of
Scutellariae Radix [22], Ginseng Radix [23], and Zizyphi
Fructus [24], the antioxidant effect of Glycyrrhizae Radix et
Rhizoma [25], and the hemolytic activities of Bupleuri
Radix [26]. The composition of SSTW was analyzed using
high performance liquid chromatography (HPLC) in previ-
ous study [27]. The chemical standards used to identify and
quantify compounds in the SSTW were as follows: liquritin,
glycyrrhizin and baicalin (marker components). Previous
studies demonstrated that the compounds exerts multiple
biological functions and pharmacological effects such as
anti-inflammatory effect of liquritin [28], and antioxidant
effect of glycyrrhizin [29] and antiallergy effect of bai-
calin [30]. The present study aimed to investigate
whether SSTW has antiallergic effects related to
Fig. 2 Effects of SSTW on cytokine and chemokine levels in BALF. Individual values were obtained using ELISA analysis. (a) IL-4 level; (b) IL-5 level;
(c) IL-13 level; (d) IL-17 level; (e) IL-33 level; (f) eotaxin level. NC, normal control group (PBS only); OVA, OVA-induced group; Mon, montelukast
(30 mg/kg) + OVA-induced group; SSTW-100, SSTW (100 mg/kg) + OVA-induced group; SSTW-200, SSTW (200 mg/kg) + OVA-induced group.
Each bar represents the mean ± SEM (n = 6 per group). Significant differences at ##P < 0.01 compared with the NC group. Significant differences
at *P <0.05 and **P < 0.01 compared with the OVA-induced group
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Fig. 3 (See legend on next page.)
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inflammation effects through modulation of the pro-
duction of Th2-type cytokines.
The obvious mechanisms of chronic airway inflamma-
tion in asthma are incompletely known but are consid-
ered to be dependent on the sustained infiltration and
activation of numerous inflammatory cells including eo-
sinophils, neutrophils, lymphocytes, and macrophages,
followed by synthesis and release of a variety of pro-
inflammatory mediators and cytokines [31]. In particular,
among the activated cells in the pathogenesis of allergic
asthma, eosinophils are the most prominent cell type,
and an increased number in the airways is correlated
with the severity of asthma [32]; accordingly, selective
elimination of eosinophils is often a target for the ther-
apy of various inflammatory diseases including allergic
asthma. A previous study demonstrated that recruitment
of eosinophils into BALF was clearly observed as ex-
pected in the OVA-induced asthmatic mice [19]. Admin-
istration of SSTW dramatically decreased the number of
eosinophils in BALF. Our results indicate that SSTW is
an effective eosinophil-depleting agent. In addition, sev-
eral mediators secreted from eosinophils and lympho-
cytes can amplify portions of the inflammatory cascade;
they can increase airway hyperresponsiveness, inflamma-
tory cell accumulation, and stimulate mucus secretion,
both of which can contribute to airway obstruction and
remodeling [33]. In our study, we found elevated
leukocyte infiltration, goblet-cell hyperplasia, and mucus
hypersecretion, confirming a previous study [19]. To
support the previous results, our histopathological find-
ings (H&E and PAS stain) demonstrate that SSTW signifi-
cantly decreased the OVA-induced leukocyte infiltration,
goblet-cell hyperplasia, and mucus hypersecretion.
Initiation of allergic response occurs with allergen
presentation by antigen-presenting cells to CD4+ T cells.
Antigen-activated CD4+ T cells induce several character-
istic features of asthma, including the secretion of Th2-
type cytokines such as IL-4, IL-5, and IL-13, which are
responsible for IgE production by B cells and eosinophil
activation and recruitment [34, 35]. IL-4 is the most im-
portant Th2-type cytokine in inducing isotype switching
to IgE in B lymphocytes [36]. IL-5 plays a major role in
the maturation and recruitment of eosinophils into the
airway [37]. IL-13 induces many features of allergic lung
disease, including goblet cell metaplasia and mucus hy-
persecretion, which all contribute to airway obstruction
[38]. IL-17 induces the production of many other cyto-
kines (such as IL-6, G-CSF, GM-CSF, IL-1β, TGF-β, and
TNF-α), chemokines, and prostaglandins (e.g., PGE2)
from many cell types such as fibroblasts, endothelial cells,
epithelial cells, keratinocytes, and macrophages [39]. IL-33
is a potent inducer of proinflammatory cytokine and che-
mokine production by mast cells. It also induces the de-
granulation of IgE-primed mast cells and enhances mast-
cell maturation and survival [40]. Eotaxin plays a role in
airway remodeling through recruitment of eosinophils and
mast cells, which have profibrogenic activity [41]. Thus,
these Th2-type cytokines induce inflammatory responses,
Fig. 4 Effects of SSTW on total and OVA-specific IgE levels in plasma.
Data were obtained using ELISA analysis. a Total IgE level and (b)
OVA-specific IgE level. NC, normal control group (PBS only); OVA,
OVA-induced group; Mon, montelukast (30 mg/kg) + OVA-induced
group; SSTW-100, SSTW (100 mg/kg) + OVA-induced group; SSTW-200,
SSTW (200 mg/kg) + OVA-induced group. Each bar represents the
mean ± SEM (n = 6 per group). Significant differences at ##P < 0.01
compared with the NC group. Significant differences at **P < 0.01
compared with the OVA-induced group
(See figure on previous page.)
Fig. 3 Effects of SSTW on recruitment of leukocytes and mucus production in lung tissue. Lung tissues were stained with (a) H&E and (b)
periodic acid–Schiff (PAS) solution (magnification 200 ×). a and b Representative photomicrographs of lung sections are shown (n = 6 per group).
c Inflammation index and (d) mucus production index were determined using an image analyzer. NC, normal control group (PBS only); OVA,
OVA-induced group; Mon, montelukast (30 mg/kg) + OVA-induced group; SSTW-100, SSTW (100 mg/kg) + OVA-induced group; SSTW-200, SSTW
(200 mg/kg) + OVA-induced group. Each bar represents the mean ± SEM (n = 6 per group). Significant differences at ##P < 0.01 compared with the
NC group. Significant differences at *P < 0.05 and **P < 0.01 compared with the OVA-induced group
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such as inflammatory cells infiltration, eosinophil activa-
tion, IgE production, and mucus secretion [42]. Many
studies suggest that the anti-inflammatory effects of Th2-
type cytokines occur via diminishing its production in a
mouse model of allergic asthma [43, 44]. Our findings in-
dicate that SSTW significantly decreased Th2-type cyto-
kine production. This anti-inflammatory effect of SSTW
may be responsible, at least in part, for the decreased re-
cruitment of eosinophils into the lung. IgE may be an im-
portant target in treatments for allergy and asthma and is
closely associated with Th2-type responses. Administra-
tion of SSTW markedly attenuated the increased total and
OVA-specific IgE levels in plasma. These findings support
the evidence that SSTW regulates the Th2-type immune
response in an asthmatic mouse model. Therefore, SSTW
may have potential as an effective antiasthma agent
through decrease of IgE levels.
An imbalance between the oxidative forces and the anti-
oxidant defense systems favoring an oxidative injury has
been implicated in the pathogenesis of asthma [45]. Oxi-
dative injury leads to an augmentation of the existing in-
flammation that is a hallmark of asthma. One of these
defense mechanisms is the induction of a stress-response
protein, HO-1. Therefore, to determine a factor related to
oxidative stress we measured HO-1 expression. HO-1, a
protective gene, is a highly inducible enzyme that defends
cells against oxidative stress and is induced in a mouse
model of asthma. Moreover, its deficiency leads to an
Fig. 5 Effects of SSTW on HO-1 level and protein expression. Data were obtained using (a) ELISA analysis and (b) immunohistochemistry. NC,
normal control group (PBS only); OVA, OVA-induced group; Mon, montelukast (30 mg/kg) + OVA-induced group; SSTW-100, SSTW (100 mg/kg) + OVA-
induced group; SSTW-200, SSTW (200 mg/kg) + OVA-induced group. Each bar represents the mean ± SEM (n = 6 per group). Significant differences
at ##P < 0.01 compared with the NC group. Significant differences at *P <0.05 compared with the OVA-induced group
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increase in chronic inflammation and leukocyte recruit-
ment [46]. Previous studies reveal that the induction of
HO-1 helps to reduce tissue injury and inflammation in a
models of experimental asthma [47–49]. It was suggested
that HO-1 induction occurs as a protective mechanism
against oxidant-mediated cellular injury representing re-
active oxygen species production [50]. Our results confirm
that SSTW overexpressed OVA-induced production of
HO-1, suggesting that the protective effect of SSTW is re-
lated to its reduction of oxidative stress. Increased HO-1
protein expression may be due to the induction of the en-
zyme by inflammatory mediators present in the asthmatic
airway. Many cytokines and oxidants involved in asth-
matic inflammation including interleukins are able to in-
duce HO-1 expression in cell lines and tissues under
experimental conditions [51]. Taken together, our findings
demonstrate that SSTW provides cytoprotection through
overexpression of HO-1 induced by Th2-type cytokines.
Mon is a CysLT1 receptor antagonist used for the main-
tenance treatment of asthma to relieve allergic symptoms.
Mon inhibits the action of leukotriene D4 on the CysLT1
receptor in the lung, which reduces bronchoconstriction
and airway inflammation [52, 53]. In present study, Mon
reduces the eosinophilic airway inflammation, and de-
crease the release of Th2-type cytokines, chemokine,
IgE and mucus hypersecretion. However, the regulation
of HO-1 have not worked. Treatment of SSTW reduces
asthmatic responses by providing similar result to Mon.
In addition, activation of HO-1 attenuated airway in-
flammation by administration of SSTW in mice with
OVA-induced asthma. Considering the overall results,
our findings demonstrate that SSTW exerts antiasth-
matic effects on OVA-induced airway inflammation,
and that HO-1 induction may be at least partly respon-
sible for its action.
Conclusions
Our findings demonstrate that SSTW significantly in-
hibits OVA-induced asthmatic reaction by reduction of
leukocytes, eosinophilic inflammation and downregula-
tion of Th2-type cytokines, chemokines, and decrease
of mucus hypersecretion, IgE levels and upregulation of
HO-1 expression. Therefore, SSTW may prove to be a
useful therapeutic agent for the treatment of allergic
airway diseases.
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